Skip to main content
. 2018 Jul 31;5(8):ofy187. doi: 10.1093/ofid/ofy187

Table 4.

Antifungal Use, by IFI Category

All Cases Candida Other Yeast Cryptococcus Aspergillus Other Hyaline Mold Mucorales Dimorphic Fungi Dematiaceous Mold Species Not Available
All, No. 3374 1862 (55.2) 51 (1.5) 40 (1.2) 301 (8.9) 33 (1.0) 36 (1.1) 849 (25.2) 28 (0.8) 222 (6.6)
Antifungal
 Amphotericin B 341 (10.1) 144 (7.7) 10 (19.6) 20 (50) 90 (29.9) 8 (24.2) 24 (66.7) 31 (3.7) 7 (25.0) 29 (13.1)
 Anidulafungin 32 (0.9) 20 (1.1) 1 (2.0) 0 (0) 11 (3.7) 0 (0) 1 (2.8) 0 (0) 0 (0) 3 (1.4)
 Caspofungin 642 (19) 460 (24.7) 10 (19.6) 4 (10) 113 (37.5) 7 (21.2) 13 (36.1) 12 (1.4) 6 (21.4) 42 (18.9)
 Micafungin 474 (14) 296 (15.9) 19 (37.3) 5 (12.5) 83 (27.6) 7 (21.2) 9 (25) 18 (2.1) 2 (7.1) 59 (26.6)
 Fluconazole 1515 (44.9) 1152 (61.9) 19 (37.3) 23 (57.5) 6 (18.2) 194 (22.9) 3 (10.7) 73 (32.9)
 Isavuconazonium 8 (0.2) 0 (0) 1 (2.0) 0 (0) 4 (1.3) 0 (0) 0 (0) 0 (0) 0 (0) 4 (1.8)
 Itraconazole 22 (0.7) 2 (0.1) 0 (0) 0 (0) 4 (1.3) 0 (0) 0 (0) 12 (1.4) 0 (0) 4 (1.8)
 Posaconazole 86 (2.5) 18 (1) 6 (11.8) 0 (0) 34 (11.3) 3 (9.1) 12 (33.3) 4 (0.5) 3 (10.7) 17 (7.7)
 Voriconazole 307 (9.1) 88 (4.7) 8 (15.7) 5 (12.5) 151 (50.2) 15 (45.5) 11 (1.3) 7 (25.0) 36 (16.2)

Data are presented as No. (%).

Abbreviation: IFI, invasive fungal infection.